Vilos Angelos G, Vilos George A, Hollett-Caines Jackie, Garvin Greg, Kozak Roman, Abu-Rafea Basim
The Fertility Clinic, London Health Sciences Centre, London ON; Department of Obstetrics and Gynecology, Western University, London ON.
Department of Radiology, Western University, London ON.
J Obstet Gynaecol Can. 2014 Nov;36(11):983-989. doi: 10.1016/S1701-2163(15)30411-4.
To evaluate the efficacy and post-procedural pain associated with uterine artery embolization (UAE) using Gelfoam alone versus Embospheres plus Gelfoam in women with symptomatic uterine fibroids.
We conducted a prospective, non-randomized pilot study. Fluoroscopy-guided trans-femoral artery UAE was performed using Gelfoam pledgets alone or Embospheres (500 to 700 mg) plus Gelfoam under conscious sedation and local anaesthesia. This was followed by patient-controlled analgesia (PCA) using a morphine pump overnight. Post-procedural pain was assessed by the mean amount of self-administered morphine delivered by PCA pump (mL) from 0 to 19 hours in each group. The mean volumes of the uterus and the dominant fibroid were calculated by ultrasound at baseline, three months, six months, and 12 months.
A total of 17 women participated in the study. Bilateral uterine artery occlusion was performed in eight women using Gelfoam alone, and in nine women using Embosphere + Gelfoam. One woman in the Embosphere + Gelfoam group developed a puncture-site hematoma requiring further intervention one week later. The mean (SD) amount of morphine self-administered by PCA pump at time 0, 1, and 2 hours was 3.4 mg (3.1), 2.9 mg (2.2), and 2.4 mg (3.3) in the Gelfoam-only group and 6.1 mg (3.0), 9.6 mg (7.1), and 5.3 mg (4.4) in the Embosphere + Gelfoam group, respectively. After three hours, the amount of morphine used was equal in both groups. The mean (SD) total dose of morphine used was 29.5 mg (18.6) in the Gelfoam group and 41.1 mg (19.3) in the Embosphere + Gelfoam group (P = 0.228). At 12 months, the reduction in median total uterine volume and median dominant fibroid volume in each group was equal.
Clinical outcomes were equivalent after uterine artery embolization using Gelfoam alone versus Gelfoam + Embospheres. Although the amount of immediate post-procedure pain may be less with Gelfoam alone, we could not demonstrate this objectively using morphine use as a measure of pain.
评估单独使用明胶海绵与使用Embospheres微球加明胶海绵进行子宫动脉栓塞术(UAE)治疗有症状子宫肌瘤女性的疗效及术后疼痛情况。
我们开展了一项前瞻性、非随机的试点研究。在清醒镇静和局部麻醉下,通过荧光透视引导经股动脉进行UAE,单独使用明胶海绵小块或使用Embospheres微球(500至700毫克)加明胶海绵。随后使用吗啡泵进行患者自控镇痛(PCA),持续一夜。通过PCA泵在每组0至19小时内自行给药的吗啡平均量(毫升)评估术后疼痛。在基线、3个月、6个月和12个月时,通过超声计算子宫和主要肌瘤的平均体积。
共有17名女性参与研究。8名女性单独使用明胶海绵进行双侧子宫动脉栓塞,9名女性使用Embospheres微球加明胶海绵进行栓塞。Embospheres微球加明胶海绵组中有1名女性在一周后出现穿刺部位血肿,需要进一步干预。在仅使用明胶海绵组中,PCA泵在0、1和2小时自行给药的吗啡平均(标准差)量分别为3.4毫克(3.1)、2.9毫克(2.2)和2.4毫克(3.3),在Embospheres微球加明胶海绵组中分别为6.1毫克(3.0)、9.6毫克(7.1)和5.3毫克(4.4)。3小时后,两组使用的吗啡量相等。仅使用明胶海绵组使用的吗啡平均(标准差)总量为29.5毫克(18.6),Embospheres微球加明胶海绵组为41.1毫克(19.3)(P = 0.228)。在12个月时,每组子宫总体积中位数和主要肌瘤体积中位数的减少量相等。
单独使用明胶海绵与使用明胶海绵加Embospheres微球进行子宫动脉栓塞术后的临床结果相当。虽然单独使用明胶海绵术后即刻疼痛量可能较少,但我们无法以吗啡用量作为疼痛指标进行客观证明。